Overview

Cleerly Health improves heart disease treatment through a digital platform that uses artificial intelligence to analyze coronary computed tomography angiography (CCTA) imaging. This technology helps clinicians detect atherosclerosis earlier and create personalized treatment plans by providing detailed insights into plaque characteristics. Unlike traditional methods, Cleerly's approach allows for a more precise risk assessment of heart attacks. The company's goal is to enhance patient outcomes while also benefiting healthcare providers financially.

Simplify's Take

What believers are saying

• AI in cardiovascular imaging is projected to grow significantly, benefiting Cleerly's market position.
• Cleerly's recent $106M funding supports scaling commercial growth and clinical evidence generation.
• Partnerships with companies like Viz.ai enhance Cleerly's product offerings and market reach.

What critics are saying

• Increased competition from companies like Viz.ai could challenge Cleerly's market share.
• Rapid AI advancements may outpace Cleerly's current offerings, affecting competitiveness.
• Reliance on venture capital funding poses financial risks if future rounds underperform.

What makes Cleerly unique

• Cleerly uses AI to analyze coronary CT angiography for early atherosclerosis detection.
• The company offers personalized treatment plans through its AI-based digital care platform.
• Cleerly's solutions go beyond traditional measures by quantifying types of plaque.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$417.8M

Above

Industry Average

Funded Over

3 Rounds

Notable Investors:

Insight PartnersGeneral CatalystBattery Ventures

Notable Investors:

Insight PartnersGeneral CatalystBattery Ventures

$106,000,000

Series C

Dec 2024

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.

Series C Funding Comparison

Above Average

Industry standards

Ind Avg. $50M

$16M

$40M

$50M

$62M

$100M

$106M

View all funding stages